United Kingdom Archives

News and Trends 17 Jul 2015

TC BioPharm raises €1.7M to commence treatment in UK cancer patients

TC BioPharm raised €1.7M (£1.18) to treat UK-based patients with melanoma, lung and kidney cancer. Thanks to this funding, the Phase I/II clinical studies will start as of September in several parts of the country. TC BioPharm’s lead product, ImmuniCell, uses patients’ own cells grown in culture to target a wide variety of different cancers. […]

July 17, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 17 Jul 2015

GSK and Partners Bavarian Nordic and J&J Ebola vaccine candidates both reach Phase II

In outbreak situations such as the Ebola crisis, vaccines play an essential role that was largely needed during the 2014 health emergency, especially when the plague reached the First World. To ensure preparedness against Ebola, now and in the future, companies have been rushing to develop vaccines against this disease. GSK has come up with […]

July 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Jul 2015

Imperial Innovations receives a €71M loan from the European Investment Bank

Imperial Innovations secured another loan facility from the European Investment Bank (EIB) to support the company’s investments in the UK biotech and life science sector. This €71.3M (£50 million) funding follows a previous €42.9M (£30 million) loan granted by the EIB in July 2013. The European Investment Bank, which last year provided €13.3Bn to enhance […]

July 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Jul 2015

Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever

Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private investors to push forward its T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune diseases. This substantial amount of cash not only embodies the largest private investment ever made in Europe by a biotech company, but also the second […]

July 16, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 15 Jul 2015

Personalized Cancer medicines are becoming reality thanks to AstraZeneca and Qiagen’s newly approved combo

A new success for personalized medicines against cancer! AstraZeneca and Qiagen’s collaboration has achieved a major milestone after receiving the FDA’s approval of Iressa, a first-line treatment for a common form of lung cancer. The drug candidate is paired with Qiagen’s therascreen EGRF test as a companion diagnostic test. There is no doubt: the future […]

July 15, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 15 Jul 2015

GSK becomes the first Pharma to collaborate with the Francis Crick Institute

The future Francis Crick Institute has established its first industrial collaboration, even before opening its doors. And the lucky nominee couldn’t have been any other than GlaxoSmithKline, the UK’s largest pharmaceutical company. The partners are seeking to better understand human diseases, hoping that the research will lead to innovative drugs against a broad range of disorders. The […]

July 15, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 13 Jul 2015

ReNeuron backed by First-Class Investor Woodford to advance Stem Cell Therapy

The stem cell therapy developer ReNeuron raised €96M to conduct further clinical trials of its pipeline, and more specifically to pursue potential stroke, eye disease, and cancer treatments. The financial placement is supported by the already major shareholder Woodford Investment Management, allowing the latter to possess more than one-third of the company shares. ReNeuron, a […]

July 13, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 8 Jul 2015

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

Good news for patients suffering from cystic fibrosis! Imperial Innovations‘ patented gene therapy could improve the patients’ breathing provoking any side effects. An innovation that could help fulfill this unmet medical need. Cystic fibrosis is the most common deadly genetic disease in Europe. Gene deficiency leads to thickening mucus that obstructs lungs and results in […]

July 8, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 7 Jul 2015

DIY-Morphine is around the corner with recent Discoveries in Poppies

Bioproduction of future painkillers such as morphine could become a reality. Researchers from the University of York and GlaxoSmithKline Australia made crucial genetic discoveries in the morphinan synthesis pathway, which will allow its production in microbial systems or in genetically selected plant breeds. Opioid alkaloids have been used as painkillers since the dawn of time. The opium latex is […]

July 7, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 3 Jul 2015

Lilly Cooperates with Immunocore to Fight Skin Cancer

Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore‘s lead T cell receptor-based drug, IMCgp100 is tested in combination with Lilly’s kinase inhibitors galunisertib and merestinib. This second collaboration between these two companies aims to increase drug efficacy against melanoma cancer. Melanomas are rare forms of skin cancer, that have a high potential […]

July 3, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 3 Jul 2015

Nobel Prize’s company start gathering robust clinical data in two phases II

Cell Therapy’s Tendoncel, a topical gel for the treatment of severe tendon injuries, has successfully completed its phase II. The optimistic results from the clinical trial add to those of the company’s leading product, released last week. The UK company has finally started to collect strong clinical data to support its approach. Cell Therapy Limited […]

July 3, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 3 Jul 2015

Yes! Humanity can finally produce Oxygen!

Julian Melchiorri, a student of the Royal College of Art of London is making quite of a buzz outside of Scientists frontiers with his Silk Leaf. A revolutionary material capable of producing O2 from CO2 designed on biomimicry principle. Info or Intox? We’ll let you make your own mind up on the question! For a few years now, […]

July 3, 2015 - 3 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

TC BioPharm raises €1.7M to commence treatment in UK cancer patients

GSK and Partners Bavarian Nordic and J&J Ebola vaccine candidates both reach Phase II

Imperial Innovations receives a €71M loan from the European Investment Bank

Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever

Personalized Cancer medicines are becoming reality thanks to AstraZeneca and Qiagen’s newly approved combo

GSK becomes the first Pharma to collaborate with the Francis Crick Institute

ReNeuron backed by First-Class Investor Woodford to advance Stem Cell Therapy

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

DIY-Morphine is around the corner with recent Discoveries in Poppies

Lilly Cooperates with Immunocore to Fight Skin Cancer

Nobel Prize’s company start gathering robust clinical data in two phases II

Yes! Humanity can finally produce Oxygen!

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!